Pamela   Kunz, MD

Pamela Kunz, MD

Yale Cancer Center/Smilow Cancer Hospital

Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology

Expertise: NeuroendocrineMedical OncologyGastrointestinal Cancers

Dr. Kunz joins Yale from Stanford University School of Medicine where she was Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship. Beyond her record of accomplishment in GI Oncology, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis.

Education & Training:
Oncology Fellow-Stanford University (2008)
Chief Resident-Stanford University (2005)
Internal Medicine Resident-Stanford University (2004)
MD-Dartmouth Medical School (2001)
BA-Dartmouth College, Biology (1994)

No Clipping

No Research/Citations

Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians

The complete “Top Doctors” list appears in the May 2023 issue of Connecticut Magazine. Congratulations to this year’s “Top Doctors” affiliated with Smilow Cancer Hospital and Yale Cancer Center.
01-May-2023 10:00:21 AM EDT

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video